Clinical Practice Guideline for Red Blood Cell Transfusion Thresholds in Very Preterm Neonates

Area of Science:

• Neonatal Medicine
• Hematology
• Clinical Practice Guidelines

Background:

• Red blood cell (RBC) transfusion is a common intervention for anemia in very preterm neonates.
• Optimal transfusion practices, including specific hemoglobin thresholds, remain uncertain.

Purpose of the Study:

• To establish evidence-based recommendations for clinicians regarding RBC transfusions in very preterm neonates.
• To provide guidance on appropriate transfusion thresholds to improve clinical outcomes.

Main Methods:

• Systematic review of 6 randomized clinical trials (RCTs) involving 3483 participants.
• Utilized the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach.
• Consensus development by an international steering committee with stakeholder and parent input.

Main Results:

• Moderate certainty of evidence suggests low transfusion thresholds have minimal impact on short-term and long-term outcomes.
• Recommended hemoglobin thresholds vary by postnatal age and respiratory support needs.
• Specific thresholds range from 7 to 11 g/dL based on clinical context.

Conclusions:

• A restrictive RBC transfusion strategy is recommended for preterm neonates (<30 weeks' gestation).
• This guideline provides a framework for managing anemia in this vulnerable population.
• Evidence supports individualized transfusion thresholds based on clinical status.